Showing results (391-400 of 682) with videos related to

Sort By:
Pageof 69
International Journal of Cancer|February 15, 1989
An anti-CD5 immunotoxin for chronic lymphocytic leukemia: enhancement of cytotoxicity with human serum albumin-monensinA A Hertler, D M Schlossman, M J Borowitz, et al.
Cellular Immunology|November 1, 1992
Activation of T cells through a T cell-specific epitope of CD45Y Torimoto, N H Dang, M Streuli, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 11, 1994
Role of CD26/dipeptidyl peptidase IV in human immunodeficiency virus type 1 infection and apoptosisC Morimoto, C I Lord, C Zhang, et al.
The Journal of Experimental Medicine|October 1, 1989
Activation of CD4 cells by fibronectin and anti-CD3 antibody. A synergistic effect mediated by the VLA-5 fibronectin receptor complexT Matsuyama, A Yamada, J Kay, et al.
Biophysical Journal|July 5, 2005
X-ray reflectivity studies of cPLA2{alpha}-C2 domains adsorbed onto Langmuir monolayers of SOPCSárka Málková, Fei Long, Robert V Stahelin, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 1, 1991
1F7 (CD26): a marker of thymic maturation involved in the differential regulation of the CD3 and CD2 pathways of human thymocyte activationN H Dang, Y Torimoto, K Shimamura, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 10, 1997
CD27, a member of the tumor necrosis factor receptor family, induces apoptosis and binds to Siva, a proapoptotic proteinK V Prasad, Z Ao, Y Yoon, et al.
The American Journal of Medicine|May 1, 1988
Abnormalities in CD4+ T-lymphocyte subsets in inflammatory rheumatic diseasesC Morimoto, P L Romain, D A Fox, et al.
The Journal of Clinical Investigation|May 1, 1988
Requirements for the construction of antibody heterodimers for the direction of lysis of tumors by human T cellsC F Scott, W A Blättler, J M Lambert, et al.
The Journal of Cardiovascular Surgery|September 1, 1985
Enhanced myocardial protection from preoperative carbohydrate infusion in addition to maintained beta-blockadeH Berggren, R Ekroth, A Hjalmarson, et al.
Pageof 69